ClinicalTrials.Veeva

Menu

Early Prediction of Gestational Diabetes in High-risk Women Based on Breath Metabolomics

T

Tianjin Central Hospital of Gynecology Obstetrics

Status

Invitation-only

Conditions

Gestational Diabetes

Study type

Observational

Funder types

Other

Identifiers

NCT06753734
2024KY081

Details and patient eligibility

About

This study aim to develope novel breath markers of gestational diabetes through a prospective high-risk population cohort study and achieve early prediction of gestational diabetes based on an interpretable machine learning model.

Enrollment

600 estimated patients

Sex

Female

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Eligibility Criteria

  • 18-55 years old
  • 11-14 weeks of pregnancy
  • at least one risk factor for GDM
  • signed a written informed consent

Exclusion Criteria:

  • Diabetes mellitus or abnormal glucose metabolism before pregnancy
  • Hyperemesis gravidarum (urine ketone positive))
  • Thyroid dysfunction
  • Asthmatic patients
  • Hypertensive diseases that are difficult to control
  • Severe hepatic and renal insufficiency or severe electrolyte disturbance
  • Malignant tumor
  • Acute inflammation
  • lung disease
  • Patients with gastritis, duodenum and other digestive system diseases
  • Those with upper respiratory or oral problems who cannot cooperate with expiratory collection
  • smoker

Trial design

600 participants in 2 patient groups

Gestational Diabetes Group
control group

Trial contacts and locations

1

Loading...

Central trial contact

Yifan Fan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems